Story perspectives

Talc Safety Commentary Retraction Sparks Health Data Lawsuit

3/28/2026

Summary

Story summary

The Lancet retracted a 49-year-old commentary supporting talc safety linked to a Johnson & Johnson consultant.
Researchers explain why some Vietnam War veterans exposed to Agent Orange develop severe bone marrow cancers.
The Society for Immunotherapy of Cancer issued updated renal cell carcinoma guidelines.
Phase II study shows tumor treating fields with atezolizumab improving pancreatic cancer outcomes.
A Vermont patient filed a class action against Novartis for sharing health data.

1 of 1

Story summary

The Lancet retracted a 49-year-old commentary supporting talc safety linked to a Johnson & Johnson consultant.
Researchers explain why some Vietnam War veterans exposed to Agent Orange develop severe bone marrow cancers.
The Society for Immunotherapy of Cancer issued updated renal cell carcinoma guidelines.
Phase II study shows tumor treating fields with atezolizumab improving pancreatic cancer outcomes.
A Vermont patient filed a class action against Novartis for sharing health data.